Jump to content

Abbvie Canada has reversed the decision to discontinue VIBERZI


Recommended Posts

More good news. This morning I received another email from Health Canada. Much of it is the same as the email I received from them via my member of parliament's office, which I shared here on September 11. But this time Health Canada included a more definitive statement about their intention to keep Viberzi available in Canada by extending the ‘Date after which drug may no longer be imported’ on the List of Drugs for Exceptional Importation and Sale. From this morning's email:

Quote

The ‘Date after which drug may no longer be imported’ on the List of Drugs for Exceptional Importation and Sale allowing AbbVie to import US-authorized Viberzi into Canada is currently listed as January 1, 2024. The January 1, 2024 date will be extended as necessary to facilitate continued and uninterrupted access to Viberzi in Canada.

Below I copied the entire email they sent to me this morning:

Quote

Good morning,

Thank you for your correspondence concerning the availability of VIberzi.

Health Canada recognizes how important Viberzi is to the many Canadian patients who rely on it in the treatment of irritable bowel syndrome. Ensuring the people of Canada can get the medicines they need is one of Health Canada’s top priorities.

AbbVie is reporting shortages of their two strengths (75mg and 100mg) of Viberzi. The company reported that the shortages began in July and September 2022 with an unknown end-date. This is due to a shortage of one of the medicinal ingredients that is used to make the product.

As you are aware, to help mitigate the impacts of the shortage, Health Canada authorised AbbVie’s proposal to import US-authorized Viberzi into Canada. This is an exceptional and temporary measure to help maintain the supply of the drug for people requiring this drug in Canada.

The ‘Date after which drug may no longer be imported’ on the List of Drugs for Exceptional Importation and Sale allowing AbbVie to import US-authorized Viberzi into Canada is currently listed as January 1, 2024. The January 1, 2024 date will be extended as necessary to facilitate continued and uninterrupted access to Viberzi in Canada.

Health Canada is closely monitoring the availability of the drug and is actively following up with the AbbVie and our health care system partners to determine when Canadian authorized product is back in sufficient supply to consider the product out of shortage.

Sincerely, 

Regulatory Operations and Enforcement Branch
Health Canada / Government of Canada

 

  • Like 1
Link to comment
Share on other sites

  • 1 month later...

Well dang you are my new Super Hero 🦸‍♂️ ❣️😂. I only tried my Provincial Government Minister of Health way back and just got high blood pressure.  
Thank you so much for providing the links.  I know I am late reading but much appreciate your hard work.

My pharmacy closed so we transferred our prescriptions and the new one at our Save On has been super to both of us.  I may just order a 3 month supply to be on the safe side next time.  Many thanks

  • Like 1
Link to comment
Share on other sites

  • 3 months later...

I noticed with relief this week that the Health Canada website shows the license to import Viberzi from the US has been extended to January 2025.

Hope all of you are doing well!

  • Like 1
Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...